-
1دورية أكاديمية
المؤلفون: Voorham, Jaco, Corradi, Massimo, Papi, Alberto, Vogelmeier, Claus F., Singh, Dave, Fabbri, Leonardo M., Kerkhof, Marjan, Kocks, Janwillem H., Carter, Victoria, Price, David
المصدر: Voorham , J , Corradi , M , Papi , A , Vogelmeier , C F , Singh , D , Fabbri , L M , Kerkhof , M , Kocks , J H , Carter , V & Price , D 2019 , ' Comparative effectiveness of triple therapy versus dual bronchodilation in COPD ' , ERJ Open Research , vol. 5 , no. 3 . https://doi.org/10.1183/23120541.00106-2019Test
مصطلحات موضوعية: acetylcysteine, antibiotic agent, azithromycin, beta adrenergic receptor stimulating agent, carbocisteine, corticosteroid, erythromycin, long acting drug, methylxanthine, muscarinic receptor blocking agent, nedocromil, phosphodiesterase IV inhibitor, salbutamol, short acting drug, theophylline, acute respiratory tract disease, aged, article, asthma, body mass, bronchodilatation, Charlson Comorbidity Index, chronic obstructive lung disease, clinical outcome, cohort analysis, comparative study, disease exacerbation, disease severity, dyspnea, eosinophil count
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1183/23120541.00106-2019Test
https://hdl.handle.net/11370/9dafda52-bebc-4302-b5bd-983b40141178Test
https://research.rug.nl/en/publications/9dafda52-bebc-4302-b5bd-983b40141178Test
https://pure.rug.nl/ws/files/121201619/Comparative_effectiveness_of_triple.pdfTest -
2دورية أكاديمية
المؤلفون: Tzanakis N., Koulouris N., Dimakou K., Gourgoulianis K., Kosmas E., Chasapidou G., Konstantinidis A., Kyriakopoulos C., Kontakiotis T., Rapti A., Gaga M., Kalafatakis K., Kostikas K.
المصدر: BMC Pulmonary Medicine ; https://www.scopus.com/inward/record.uri?eid=2-s2.0-85110150196&doi=10.1186%2fs12890-021-01576-6&partnerID=40&md5=de3391380c16ef2288aaca597f1f813bTest
مصطلحات موضوعية: antibiotic agent, antioxidant, beta adrenergic receptor stimulating agent, bronchodilating agent, corticosteroid, glucocorticoid, methylxanthine, mucolytic agent, muscarinic receptor blocking agent, phosphodiesterase IV inhibitor, adult, aged, Article, body mass, cardiovascular disease, chronic obstructive lung disease, comorbidity, COPD Assessment Test, cross-sectional study, disease classification, disease severity, female, forced expiratory volume, forced vital capacity, Greece, heart rate, hospitalization, lung function, male, obesity
-
3دورية أكاديمية
المؤلفون: CAZZOLA, MARIO, ROGLIANI, PAOLA, Matera, MG, Page, C.
المساهمون: Cazzola, M, Matera, M, Rogliani, P, Page, C
مصطلحات موضوعية: 4 (4 fluorophenyl) 2 (4 methylsulfinylphenyl) 5 (4 pyridyl)imidazole, 4 [4 (4 fluorophenyl) 1 (3 phenylpropyl) 5 (4 pyridinyl) 1h imidazol 2 yl] 3 butyn 1 ol, 4 [4 (4 fluorophenyl) 5 (2 methoxy 4 pyrimidinyl) 1 imidazolyl]cyclohexanol, acetylcysteine, angiotensin 2 receptor antagonist, antioxidant, beta 2 adrenergic receptor stimulating agent, bronchodilating agent, corticosteroid, dipeptidyl carboxypeptidase inhibitor, doramapimod, enoxaparin, etanercept, glutathione derivative, glycosaminoglycan, heparin, hydroxymethylglutaryl coenzyme A reductase inhibitor, infliximab, irbesartan, mevinolin, muscarinic receptor blocking agent, phosphodiesterase IV inhibitor, pioglitazone, rosiglitazone, selenium derivative, simvastatin, superoxide dismutase, theophylline, antiinflammatory activity, atherosclerosi
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/17897727; info:eu-repo/semantics/altIdentifier/wos/WOS:000250635700007; volume:28; issue:10; firstpage:544; lastpage:550; journal:TRENDS IN PHARMACOLOGICAL SCIENCES; http://hdl.handle.net/2108/42211Test; info:eu-repo/semantics/altIdentifier/scopus/http://www.scopus.com/inward/record.url?eid=2-s2.0-34748904145&partnerID=40&md5=2bcff4100544d1a8d63dcb959c29eed4Test
-
4دورية أكاديمية
المؤلفون: Souliotis K., Kani C., Papageorgiou M., Lionis D., Gourgoulianis K.
المصدر: PLoS ONE ; https://www.scopus.com/inward/record.uri?eid=2-s2.0-84971326465&doi=10.1371%2fjournal.pone.0154960&partnerID=40&md5=cd8452443afb428a89e6c39f312089a4Test
مصطلحات موضوعية: beta adrenergic receptor stimulating agent, corticosteroid, methylxanthine, muscarinic receptor blocking agent, phosphodiesterase IV inhibitor, muscarinic agent, adult, age distribution, aged, Article, chronic obstructive lung disease, cross-sectional study, disease severity, drug response, electronic prescribing, female, Greece, human, major clinical study, male, observational study, prescription, retrospective study, sex difference, age, clinical practice, combination drug therapy, middle aged, Pulmonary Disease, Chronic Obstructive
-
5دورية أكاديمية
المؤلفون: CAZZOLA, MARIO, Matera M. G.
المساهمون: Cazzola, M, Matera, Mg
مصطلحات موضوعية: acetylcysteine, antiinflammatory agent, antioxidant, arformoterol, beta 2 adrenergic receptor stimulating agent, bronchodilating agent, budesonide, carmoterol, cholinergic receptor blocking agent, corticosteroid, fluticasone propionate, fluticasone propionate plus salmeterol, formoterol, gsk 159797, gsk 159802, gsk 233705, gsk 597901, gsk 678007, gsk 685698, gw 642444, indacaterol, muscarinic receptor blocking agent, nitric oxide synthase inhibitor, nva 237, phosphodiesterase IV inhibitor, salbutamol, salmeterol, theophylline, tiotropium bromide, unclassified drug
العلاقة: volume:3; issue:3; firstpage:277; lastpage:286; journal:DRUG DISCOVERY TODAY: THERAPEUTIC STRATEGIES; http://hdl.handle.net/2108/40928Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-33751193695